Journal article
Treatment of first-void urine with Aptima Transfer Solution increases detection of high-risk HPV E6/E7 mRNA
Abstract
Because of its non-invasive nature urine testing may enable increased screening for HPV in women who avoid cervical sampling. Comparisons have shown fewer HPV positives in urine. The objectives were to compare first-void urine (FVU) treated with proteinase K (PK) to untreated FVU and cervical samples collected from women attending a colposcopy clinic using an Aptima HPV mRNA assay, and comparing the HPV rates to cytology and pathology results. …
Authors
Arias M; Jang D; Dockter J; Ratnam S; Shah A; Elit L; Smieja M; Lytwyn A; Getman D; Weinbaum B
Journal
Journal of Virological Methods, Vol. 267, , pp. 48–52
Publisher
Elsevier
Publication Date
May 2019
DOI
10.1016/j.jviromet.2019.02.007
ISSN
0166-0934
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedCervix UteriCross-Sectional StudiesEarly Detection of CancerEndopeptidase KFemaleHistological TechniquesHumansMaleMiddle AgedOncogene Proteins, ViralPapillomavirus InfectionsPreservation, BiologicalRNA, ViralSensitivity and SpecificitySpecimen HandlingUrineUterine Cervical NeoplasmsYoung AdultUterine Cervical Dysplasia